Market Overview

Will Delta Continue Flying High?




Delta Airlines (DAL) is set to release Q2 results on Thursday, July 13. Estimize and The Street have been very much in line with each other when it comes to their estimates for Delta's EPS. According to Estimize, EPS is set to increase roughly 114%, from $0.77 in FQ1'17, up to $1.65 in FQ2'17. Likewise, Wall Street is looking for an identical spike. Furthermore, it looks as though the consensus among Estimize and Wall Street remains fairly similar regarding revenue. In FQ1'17, Estimize estimated  revenue of $9.175M and Wall Street came in at $9.140M; the actual number lying at $9.140M. This quarter, both Estimize and the Street are looking for revenue to increase nearly 18%. It seems like we have been holding pretty consistent with The Street on this one and Delta is on the uptrend.

Despite airline stocks not having much popularity among investors, Delta appears to still be showing strength in an unattractive market. With a high dividend yield of about 1.5%, Delta is proving to be something to keep your eyes on. With a number of new developments, such as its recent deal with Korean Air and its current testing of using biometrics rather than boarding passes, there is going to be lots of eyes of Delta in the coming future. Despite the fact that using fingerprints and eye measurements rather than boarding passes could potentially pose privacy issues and controversy, we definitely recommend taking a closer look at this company prior to earnings announcements.

Place your estimates here!

Photo Credit: Bernal Saborio

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: Previews Travel Trading Ideas General


Related Articles (DAL)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

3 New IPOs Making History

How Marijuana Can Help Treat Addictions To Opioids, Other Rx Drugs And Alcohol